Hohenberger Peter, Kasper Bernd, Ahrar Kamran
From the Division of Surgical Oncology and Thoracic Surgery, Mannheim University Medical Center, University of Heidelberg, Theodor-Kutzer Ufer, Mannheim, Germany; Interdisciplinary Sarcoma Center, University Hospital Mannheim, Theodor-Kutzer Ufer, Mannheim, Germany; Interventional Radiology and Thoracic-Cardiovascular Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX.
Am Soc Clin Oncol Educ Book. 2013:457-64. doi: 10.14694/EdBook_AM.2013.33.457.
Soft tissue sarcomas describe a very heterogeneous group of soft tissue tumors mainly arising in the lower extremities. If diagnosed at an early stage and a complete resection of the primary tumor is achieved, the patients' prognosis is excellent. However, metastatic tumor spread is common with only limited treatment possibilities. Despite an improved insight into tumor biology of sarcomas, no notable improvement has been gained in the last 20 years regarding prognosis of patients. Metastatic lung disease has long been the preserve of systemic treatments, local treatments being considered in a purely palliative intention. Several studies have objectified benefit to the local treatment of metastases, especially in an oligometastatic state. The development of techniques for stereotactic radiotherapy on the one hand and the refusal or contraindication for surgery on the other hand inaugurated studies in this direction. Besides surgery and radiotherapy, other local modalities have been investigated in the last few years such as thermal therapy (radiofrequency and laser ablation) or combined modalities (isolated limb perfusion and deep-wave hyperthermia plus chemotherapy) to help patients with metastatic soft tissue sarcoma. Minimally invasive, image-guided therapies such as thermal ablation should be considered particularly in patients who are not suitable surgical candidates or may have exhausted all other viable surgical options. Some of these techniques will be reviewed in this article, and their value for the patients will be evaluated in the light of indication from tumor biology and technical feasibility. These highly selected and specific procedures should only be performed after decision making in an interdisciplinary sarcoma-board.
软组织肉瘤是一类非常异质性的软组织肿瘤,主要发生在下肢。如果在早期诊断并实现原发肿瘤的完整切除,患者的预后极佳。然而,肿瘤转移很常见,而治疗选择有限。尽管对肉瘤的肿瘤生物学有了更深入的了解,但在过去20年里,患者的预后并没有显著改善。转移性肺部疾病长期以来一直是全身治疗的范畴,局部治疗仅出于纯粹的姑息目的。多项研究已证实局部治疗转移灶有益,尤其是在寡转移状态下。一方面立体定向放射治疗技术的发展,另一方面手术的拒绝或禁忌,开创了这方面的研究。除了手术和放疗,近年来还研究了其他局部治疗方法,如热疗(射频和激光消融)或联合治疗(隔离肢体灌注和深部热疗加化疗),以帮助转移性软组织肉瘤患者。对于不适合手术或可能已用尽所有其他可行手术选择的患者,应特别考虑热消融等微创、影像引导治疗。本文将对其中一些技术进行综述,并根据肿瘤生物学指征和技术可行性评估它们对患者的价值。这些高度选择和特定的程序应仅在跨学科肉瘤委员会做出决策后进行。